Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis

Molecular Microbiology

Volumn 38, Issue 3, 2000, Pages 514-525

  Slayden, R A ^a   Lee, R E ^a   Barry, C E ^a  

^a Twinbrook 11 Facility   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE; ACYL CARRIER PROTEIN; FATTY ACID SYNTHASE; ISONIAZID; MYCOLIC ACID; THIOLACTOMYCIN; TRICLOSAN;

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS RESISTANCE; DRUG MECHANISM; DRUG TARGETING; GENE OVEREXPRESSION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

3-OXOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE; ACETYLTRANSFERASES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MICROBIAL; ENZYME INHIBITORS; HUMANS; ISONIAZID; LIPIDS; MICROBIAL SENSITIVITY TESTS; MULTIENZYME COMPLEXES; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; OPERON; OXIDOREDUCTASES; THIOPHENES; TRICLOSAN;

EID: 0033709606     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2000.02145.x     Document Type: Article

References (46)

1. Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery
2. InhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis
3. Mycolic acids: Structure, biosynthesis and physiological functions
4. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention
5. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
6. Biosynthesis of Membrane lipids
7. The salicylate-derived mycobactin siderophores of mycobacterium tuberculosis are essential for growth in macrophages
8. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: Implications for sensitivity to isoniazid
9. The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid
10. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis
11. Global tuberculosis incidence and mortality during 1990-2000
12. The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis: Identification and functional analysis of CMAS-2
13. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: A molecular study
14. Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin
15. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing
16. Thiolactomycin and related-analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis
17. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore
18. Molecular basis of triclosan activity
19. A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates
20. Triclosan targets lipid synthesis
21. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan
22. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II
23. Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis
24. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid
25. Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium
26. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: Restricted array of mutations associated with drug resistance
27. Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli
28. Inhibition of InhA, the enoyl reductase from mycobacterium tuberculosis, by triclosan and isoniazid
29. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: Implications for rapid susceptibility testing
30. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis
31. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis
32. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria
33. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis
34. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods
35. The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis
36. Antimycobacterial action of thiolactomycin: An inhibitor of fatty acid and mycolic acid synthesis
37. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
38. Structural basis and mechanism of enoyl reductase inhibition by triclosan
39. Overproduction of a functional fatty acid biosynthetic enzyme blocks fatty acid synthesis in Escherichia coli
40. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis
41. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level
42. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth
43. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan
44. Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid
45. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization
46. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis